Philip Morris stock falls, FDA advisors say evidence doesn't back claim iQOS cuts disease risk

2:13 PM ET Thu, 25 Jan 2018

An FDA advisory committee said evidence doesn't support the tobacco company's claim that iQOS cuts the risk of tobacco-related diseases.